CELLULAR IMMUNOTHERAPY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Cellular Immunotherapy Market, By Therapy Type (CAR T-Cell Therapy (Chimeric Antigen Receptor T-cell), TCR-T Cell Therapy (T-Cell Receptor T-cell), NK Cell Therapy (Natural Killer cell therapy), Dendritic Cell Therapy, Tumor-Infiltrating Lymphocytes (TIL) Therapy, Macrophage-Based Cell Therapy, and Others (emerging/novel cell types)), By Source (Autologous (patient-derived cells) and Allogeneic (donor-derived cells)), By Indication (Cancer (Hematologic Malignancies (e.g., leukemia, lymphoma, myeloma), Solid Tumors (e.g., lung, breast, melanoma, ovarian, glioblastoma)), Infectious Diseases (Viral Infections (e.g., HIV, HBV, HCV, COVID-19), Bacterial Infections (e.g., tuberculosis)), Autoimmune Disorders (Multiple Sclerosis, Rheumatoid Arthritis, Type 1 Diabetes), and Others), By Manufacturing Modality (Ex Vivo Cell Expansion and In Vivo Engineering), By End User (Hospitals and Clinics, Specialty Endocrinology and Obesity Centers, Ambulatory Surgical Centers (ASCs), Home Healthcare Services, and Others (Academic and Research Institutes, etc.)), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

Published In: 10 Mar, 2026
Code: CMI8447
Page number: 165
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Global Cellular Immunotherapy Market, By Therapy Type
  - Global Cellular Immunotherapy Market, By Source
  - Global Cellular Immunotherapy Market, By Indication
  - Global Cellular Immunotherapy Market, By Manufacturing Modality
  - Global Cellular Immunotherapy Market, By End User
  - Global Cellular Immunotherapy Market, By Region
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- Industry Trends
Global Cellular Immunotherapy Market, By Therapy Type, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- CAR T-Cell Therapy (Chimeric Antigen Receptor T-cell)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- TCR-T Cell Therapy (T-Cell Receptor T-cell)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- NK Cell Therapy (Natural Killer cell therapy)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Dendritic Cell Therapy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Tumor-Infiltrating Lymphocytes (TIL) Therapy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Macrophage-Based Cell Therapy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (emerging/novel cell types)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Cellular Immunotherapy Market, By Source, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Autologous (patient-derived cells)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Allogeneic (donor-derived cells)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Cellular Immunotherapy Market, By Indication, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    - Hematologic Malignancies (e.g., leukemia, lymphoma, myeloma)
      - Solid Tumors (e.g., lung, breast, melanoma, ovarian, glioblastoma)
- Infectious Diseases
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    - Viral Infections (e.g., HIV, HBV, HCV, COVID-19)
      - Bacterial Infections (e.g., tuberculosis)
- Autoimmune Disorders
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    - Multiple Sclerosis
      - Rheumatoid Arthritis
      - Type 1 Diabetes
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Cellular Immunotherapy Market, By Manufacturing Modality, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Ex Vivo Cell Expansion
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- In Vivo Engineering
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Cellular Immunotherapy Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Hospitals and Clinics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Specialty Endocrinology and Obesity Centers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ambulatory Surgical Centers (ASCs)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Home Healthcare Services
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Academic and Research Institutes, etc.)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Cellular Immunotherapy Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
  - Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
  - Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Manufacturing Modality, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Manufacturing Modality, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Manufacturing Modality, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Manufacturing Modality, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Manufacturing Modality, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Manufacturing Modality, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  - Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
    - South Africa
    - North Africa
    - Central Africa
Competitive landscape
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Gilead Sciences Inc (Kite Pharma)
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bristol Myers Squibb Company
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Johnson and Johnson (Janssen Biotech)
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Cellectis S.A.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Adaptimmune Therapeutics plc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Autolus Therapeutics plc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Allogene Therapeutics Inc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Atara Biotherapeutics Inc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Legend Biotech Corporation
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- bluebird bio Inc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Fate Therapeutics Inc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- ImmunityBio Inc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Iovance Biotherapeutics Inc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Poseida Therapeutics Inc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us

*Browse 32 market data tables and 28 figures on 'Cellular Immunotherapy Market' - Global forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now